These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9536234)

  • 1. Cutaneous malignant melanoma in women and the role of oral contraceptives.
    Gefeller O; Hassan K; Wille L
    Br J Dermatol; 1998 Jan; 138(1):122-4. PubMed ID: 9536234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review of case-control studies: oral contraceptives show no effect on melanoma risk.
    Pfahlberg A; Hassan K; Wille L; Lausen B; Gefeller O
    Public Health Rev; 1997; 25(3-4):309-15. PubMed ID: 9553446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case-control study of the possible association between oral contraceptives and malignant melanoma.
    Adam SA; Sheaves JK; Wright NH; Mosser G; Harris RW; Vessey MP
    Br J Cancer; 1981 Jul; 44(1):45-50. PubMed ID: 7259960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral contraceptives and skin neoplasia.
    Green A
    Contraception; 1991 Jun; 43(6):653-66. PubMed ID: 1868736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous malignant melanoma in females: the role of hormonal and reproductive factors.
    Zanetti R; Franceschi S; Rosso S; Bidoli E; Colonna S
    Int J Epidemiol; 1990 Sep; 19(3):522-6. PubMed ID: 2262243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous malignant melanoma in women: exogenous sex hormones and reproductive factors.
    Holman CD; Armstrong BK; Heenan PJ
    Br J Cancer; 1984 Nov; 50(5):673-80. PubMed ID: 6498065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
    Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of oral contraception with kidney cancer, colon cancer, gallbladder cancer (including extrahepatic bile duct cancer) and pituitary tumours.
    Milne R; Vessey M
    Contraception; 1991 Jun; 43(6):667-93. PubMed ID: 1868737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study.
    Lidegaard O
    BMJ; 1993 Apr; 306(6883):956-63. PubMed ID: 8490470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case-control study of oral contraceptives and risk of thromboembolic stroke: results from International Study on Oral Contraceptives and Health of Young Women.
    Heinemann LA; Lewis MA; Thorogood M; Spitzer WO; Guggenmoos-Holzmann I; Bruppacher R
    BMJ; 1997 Dec; 315(7121):1502-4. PubMed ID: 9420491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral contraceptives and the risk of subarachnoid hemorrhage: a meta-analysis.
    Johnston SC; Colford JM; Gress DR
    Neurology; 1998 Aug; 51(2):411-8. PubMed ID: 9710012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dermatological complications caused by oral contraceptives].
    Deharo C; Berbis P; Privat Y
    Fertil Contracept Sex; 1988 Apr; 16(4):299-304. PubMed ID: 12342376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cutaneous effects in hormonal contraception].
    Thomas P; Dalle E; Revillon B; Delecour M; Devarenne-nicolle MF; Pagniez I
    NPN Med; 1985 Jan; 5(81):19-24. PubMed ID: 12281276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal and reproductive influences and risk of melanoma in women.
    Smith MA; Fine JA; Barnhill RL; Berwick M
    Int J Epidemiol; 1998 Oct; 27(5):751-7. PubMed ID: 9839729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer among young U.S. women in relation to oral contraceptive use.
    White E; Malone KE; Weiss NS; Daling JR
    J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral contraceptives and venous thromboembolism: a case-control study designed to minimize detection bias.
    Realini JP; Encarnacion CE; Chintapalli KN; Rees CR
    J Am Board Fam Pract; 1997; 10(5):315-21. PubMed ID: 9297655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral contraceptive use and risk of cutaneous malignant melanoma in a case-control study of French women.
    Lê MG; Cabanes PA; Desvignes V; Chanteau MF; Mlika N; Avril MF
    Cancer Causes Control; 1992 May; 3(3):199-205. PubMed ID: 1610966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogens, oral contraceptives and hormonal replacement therapy increase the incidence of cutaneous melanoma: a population-based case-control study.
    Koomen ER; Joosse A; Herings RM; Casparie MK; Guchelaar HJ; Nijsten T
    Ann Oncol; 2009 Feb; 20(2):358-64. PubMed ID: 18725391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use.
    Pike MC; Henderson BE; Krailo MD; Duke A; Roy S
    Lancet; 1983 Oct; 2(8356):926-30. PubMed ID: 6138501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimates of the risk of cardiovascular death attributable to low-dose oral contraceptives in the United States.
    Schwingl PJ; Ory HW; Visness CM
    Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 1):241-9. PubMed ID: 9914611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.